|
CA1136620A
(en)
|
1979-01-08 |
1982-11-30 |
Ulf P.F. Lindahl |
Heparin fragments having selective anticoagulation activity
|
|
JPS63246396A
(ja)
*
|
1987-03-31 |
1988-10-13 |
Shiseido Co Ltd |
モノクロ−ナル抗体
|
|
FR2614026B1
(fr)
*
|
1987-04-16 |
1992-04-17 |
Sanofi Sa |
Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
|
|
SE9002550D0
(sv)
*
|
1990-08-01 |
1990-08-01 |
Kabivitrum Ab |
Heparinfragment
|
|
SE9003181D0
(sv)
|
1990-10-04 |
1990-10-04 |
Kabivitrum Ab |
Use of heparin fraction
|
|
US5250519A
(en)
|
1991-03-29 |
1993-10-05 |
Glycomed Incorporated |
Non-anticoagulant heparin derivatives
|
|
US5280016A
(en)
|
1991-03-29 |
1994-01-18 |
Glycomed Incorporated |
Non-anticoagulant heparin derivatives
|
|
JPH0532703A
(ja)
*
|
1991-07-26 |
1993-02-09 |
Terumo Corp |
低分子量ヘパリン誘導体の製造法
|
|
WO1994008595A1
(en)
*
|
1992-10-13 |
1994-04-28 |
Virginia Commonwealth University |
Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
|
|
US5527785A
(en)
|
1993-05-14 |
1996-06-18 |
The Regents Of The University Of California |
Selectin receptor modulating compositions
|
|
EP0735050B1
(en)
*
|
1995-03-31 |
2002-09-25 |
Hamilton Civic Hospitals Research Development, Inc. |
Compositions for inhibiting thrombogenesis
|
|
US5744457A
(en)
*
|
1995-03-31 |
1998-04-28 |
Hamilton Civic Hospitals Research Development Inc. |
Compositions and methods for inhibiting thrombogenesis
|
|
US5993810A
(en)
|
1996-03-15 |
1999-11-30 |
Lebovitz; Shamir Israel |
Method of softening or ripening the cervix of a female mammal using collagenase
|
|
US5767269A
(en)
*
|
1996-10-01 |
1998-06-16 |
Hamilton Civic Hospitals Research Development Inc. |
Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
|
|
AU4572797A
(en)
|
1996-10-15 |
1998-05-11 |
Toray Industries, Inc. |
Cervical canal maturing agent
|
|
GB9711443D0
(en)
*
|
1997-06-03 |
1997-07-30 |
Leo Pharm Prod Ltd |
Chemical suppositions
|
|
WO1999026984A1
(fr)
*
|
1997-11-20 |
1999-06-03 |
Ikuo Yamashina |
Modification de l'heparine de faible masse moleculaire et remede contre l'ulcere de la peau
|
|
US6596705B1
(en)
|
1998-02-09 |
2003-07-22 |
The Regents Of The University Of California |
Inhibition of L-selectin and P-selection mediated binding using heparin
|
|
US6498246B1
(en)
|
1998-02-26 |
2002-12-24 |
Seikagaku Corporation |
Glycosaminoglycan derivatives and processes for preparing same
|
|
US6028061A
(en)
|
1998-06-18 |
2000-02-22 |
Children's Medical Center Corp |
Angiogenesis inhibitors and use thereof
|
|
WO2000006608A1
(en)
*
|
1998-07-31 |
2000-02-10 |
Seikagaku Corporation |
Novel glycosaminoglycan and drug compositions containing the same
|
|
MXPA01002022A
(es)
*
|
1998-08-26 |
2002-04-24 |
Collaborative Group Ltd |
Receptor para beta-(1,3-)glucano soluble acuoso, no derivado.
|
|
CA2377734A1
(en)
*
|
1999-06-30 |
2001-01-11 |
Hamilton Civic Hospitals Research Development, Inc. |
Heparin compositions that inhibit clot associated coagulation factors
|
|
JP4897991B2
(ja)
*
|
1999-07-23 |
2012-03-14 |
ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ |
超低分子量ヘパリン組成物
|
|
IT1316986B1
(it)
|
2000-01-25 |
2003-05-26 |
Sigma Tau Ind Farmaceuti |
Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
|
|
JP4585072B2
(ja)
*
|
2000-02-29 |
2010-11-24 |
扶桑薬品工業株式会社 |
ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
|
|
DE60138115D1
(de)
*
|
2000-09-12 |
2009-05-07 |
Massachusetts Inst Technology |
Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
|
|
SE521676C2
(sv)
|
2002-01-02 |
2003-11-25 |
Dilafor Ab |
Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
|
|
EP1542704A1
(en)
|
2002-04-18 |
2005-06-22 |
Stephen H. Embury |
Method and composition for preventing pain in sickle cell patients
|
|
US8071569B2
(en)
|
2002-09-20 |
2011-12-06 |
Mousa Shaker A |
Oxidized heparin fractions and their use in inhibiting angiogenesis
|
|
JP2005106694A
(ja)
*
|
2003-09-30 |
2005-04-21 |
Mochida Pharmaceut Co Ltd |
敗血症早期検出及び重篤度評価
|
|
EP1582531A1
(en)
|
2004-03-24 |
2005-10-05 |
Aventis Pharma S.A. |
Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
|
|
US20060040896A1
(en)
*
|
2004-08-18 |
2006-02-23 |
Paringenix, Inc. |
Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
|
|
US7741311B2
(en)
|
2005-01-03 |
2010-06-22 |
Shaker Mousa |
Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
|
|
US20080214480A1
(en)
|
2005-07-22 |
2008-09-04 |
Trf Pharma, Inc. |
Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae
|
|
ZA200801696B
(en)
*
|
2005-07-22 |
2009-08-26 |
Univ California |
Heparin compositions and selection inhibition
|
|
CA2648385C
(en)
*
|
2006-04-04 |
2020-09-01 |
Singulex, Inc. |
Highly sensitive system and methods for analysis of troponin
|
|
CN101495517B
(zh)
*
|
2006-05-25 |
2012-10-10 |
莫曼塔医药品有限公司 |
低分子量肝素及其用途
|
|
WO2009007224A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Low molecular weight heparin derivatives having neuroprotective activity
|
|
US8592393B2
(en)
*
|
2007-11-02 |
2013-11-26 |
Momenta Pharmaceuticals, Inc. |
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
|
|
US8569262B2
(en)
|
2007-11-02 |
2013-10-29 |
Momenta Pharmaceuticals, Inc. |
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
|
|
EP2207811B1
(en)
*
|
2007-11-02 |
2017-01-04 |
Momenta Pharmaceuticals, Inc. |
Non-anticoagulant polysaccharide compositions
|
|
ES2567079T3
(es)
|
2007-11-02 |
2016-04-19 |
Momenta Pharmaceuticals, Inc. |
Composiciones de polisacáridos que no son anticoagulantes
|
|
WO2009073184A1
(en)
|
2007-12-03 |
2009-06-11 |
Florida State University Research Foundation, Inc. |
Compositions for inducing labor and associated methods
|
|
CA2719666C
(en)
|
2008-04-04 |
2016-08-16 |
Glenn Prestwich |
Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
|
|
WO2010111570A1
(en)
*
|
2009-03-27 |
2010-09-30 |
E. I. Du Pont De Nemours And Company |
Polyglycerol aldehydes
|
|
AU2010236222B2
(en)
|
2009-04-16 |
2015-10-15 |
Momenta Pharmaceuticals, Inc. |
Methods of assessing activity of a polysaccharide composition
|
|
AU2010268756A1
(en)
|
2009-06-30 |
2012-01-19 |
The Walter And Eliza Hall Institute Of Medical Research |
Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
|
|
EP2461821A4
(en)
*
|
2009-07-31 |
2013-07-03 |
Bayer Healthcare Llc |
MODIFIED POLYPEPTIDES OF FACTOR IX AND USES THEREOF
|
|
US9066991B2
(en)
*
|
2009-12-22 |
2015-06-30 |
Lifebond Ltd. |
Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
|
|
WO2013095215A1
(en)
|
2011-12-19 |
2013-06-27 |
Dilaforette Ab |
Low anticoagulant heparins
|
|
HK1203370A1
(en)
|
2012-03-26 |
2015-10-30 |
迪乐方有限责任公司 |
Method for treatment of labor arrest
|
|
HK1203369A1
(en)
|
2012-03-26 |
2015-10-30 |
迪乐方有限责任公司 |
Combination treatment comprising sulphated glycosaminoglycans for inducing labor
|